On December 15 [2021], Freedom to Operate filed their post-grant review on a patent filed by COMPASS on what the company claims are proprietary, lab-made formulations of psilocybin. A week later, on December 22 [2021], FTO filed a second post-grant review of a second COMPASS patent. Once I saw the patent info, I sent it…
…a team of scientists from China designed a new drug they say acts in a similar fashion to… psilocybin, but without leading to hallucinations. Sheng Wang, a biochemist with the Chinese Academy of Science and a senior author of the new study,” said, “The hallucination effects definitely restrict their potential use. But now, non-hallucinogenic drugs…
Under current U.S. codes, builders, engineers, and architects must get approval to use hempcrete on a project-by-project basis, although the material is commonly used in the United Kingdom and France and has been approved for use for 30 years in Europe. The U.S. Hemp Building Foundation, the non-profit arm of the U.S. Hemp Building Association (USHBA), earlier…
Rep. Earl Blumenauer (D-OR) (on a call with former Pennsylvania Rep. Ryan Costello)… said that while he’s yet to meet with Anne Melissa Milgram [Administrator of the Drug Enforcement Administration (DEA)], he looks forward to doing so and will convey that the psilocybin case “is a golden opportunity for that agency to get in step…
This drug, Moksha, could be seen as the mirror image of Soma: a fantastic agent for spiritual liberation that provides a full-blown mystical experience and stands at the foundation of the utopian society described in the novel… Huxley’s fascination with the threat and promise of consciousness-altering chemicals constitutes a thread that runs through his writing. Brave…
Both of these organizations have a longstanding history with drug advocacy, and this collaboration will no doubt strengthen the cause. Both DN and SSDP have accomplished many things over the years. DN is newer to the advocacy scene, having been founded in Oakland in 2019, but its efforts have grown rapidly and there are chapters…
Assemblyman… recently introduced A.8569 in the Assembly to allow the medical use of psilocybin and create a $2 million fund to help state residents who qualify pay for the mushroom-based treatment. …proposes creating a section in the state Public Health Law titled Medical Use of Psilocybin. Patients or caregivers could receive identification cards lasting one…
The comments came at a psychedelics workshop Volkow’s agency cohosted with the National Institute of Mental Health (NIMH) [in Jan. 2022]. National Institute on Drug Abuse (NIDA) Director Nora Volkow said people are going to keep using substances such as psilocybin—especially as the reform movement expands and there’s increased attention being drawn to the potential…
The Drug Enforcement Administration (DEA)… authorized two cannabis companies to harvest marijuana for research purposes… ending a five-decade federal monopoly. National Institute on Drug Abuse (NIDA) director Nora Volkow told the outlet that it would be “valuable” for researchers to use marijuana from dispensaries to examine what kind of weed is being consumed to better…
…facing a holdup at the FDA in bringing its LSD program to more patients… didn’t dive into what issues the agency flagged before it made its decision. Not a whole lot is known about the New York biotech except that Barrow, formerly interim CEO and chief development officer, stepped into the full-time CEO role about…
Recent Comments